Type 1 diabetes mellitus associated with activated phosphatidylinositol 3-kinase delta syndrome, type 2

J Diabetes. 2018 May;10(5):421-422. doi: 10.1111/1753-0407.12638. Epub 2018 Feb 12.

Authors

Ryuichi Nakagawa¹, Kei Takasawa¹, Tzu-Wen Yeh¹, Kohsuke Imai¹, Kenichi Kashimada¹, Tomohiro Morio¹

Affiliation

¹ Department of Paediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.

PMID: 29280567
DOI: 10.1111/1753-0407.12638

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Inflammatory Agents / therapeutic use
Class I Phosphatidylinositol 3-Kinases / metabolism*
Diabetes Mellitus, Type 1 / complications
Diabetes Mellitus, Type 1 / drug therapy
Diabetes Mellitus, Type 1 / pathology*
Humans
Hyperglycemia / complications
Hyperglycemia / drug therapy
Hyperglycemia / pathology*
Immunologic Deficiency Syndromes / complications
Immunologic Deficiency Syndromes / drug therapy
Immunologic Deficiency Syndromes / pathology*
Male
Prednisolone / therapeutic use
Primary Immunodeficiency Diseases
Prognosis
Young Adult

Substances

Anti-Inflammatory Agents
Prednisolone
Class I Phosphatidylinositol 3-Kinases
PIK3CD protein, human

Supplementary concepts

Activated PI3K-delta Syndrome